Star Therapeutics received FDA Rare Pediatric Disease and Breakthrough Therapy designations for VGA039 in von Willebrand disease prophylaxis.
Star Therapeutics is a clinical stage biotechnology company discovering and developing best-in-class antibodies to create life-changing therapies for patients, initially addressing unmet needs in hematology and immunology
Star Therapeutics is a clinical stage biotechnology company discovering and developing best-in-class antibodies to create life-changing therapies for patients, initially addressing unmet needs in hematology and immunology.